How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,514 results for

"covid 19" OR "novel coronavirus"

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. COVID-19 (Novel Coronavirus)

COVID-19 (Novel Coronavirus) COVID-19 (Novel Coronavirus) You need to enable JavaScript to run this app. Person Subscribe for unlimited access to DynaMed content, CME/CE & MOC credit, and email alerts on content you follow. Subscribe Already subscribed? Language English Search Cancel Specialties KeyboardArrowDown 0 COVID-19 (Novel Coronavirus) List MoreVert AddCircleOutline Follow Share Share AddCircleOutline Follow Share Share General Information Description acute respiratory disease caused (...) by a novel coronavirus (SARS-CoV-2) first identified in December 2019 in Wuhan, Hubei Province, China and spreading worldwide ( ) PubMed 32123347 Nature microbiology Nat Microbiol 20200302 SARS-CoV-2 is a member of beta genus coronaviruses closely related to SARS-CoV ( ) common signs of COVID-19 include fever, cough, and shortness of breath ( ) there is no specific antiviral treatment for COVID-19, but supportive care may help to relieve symptoms and should include support of vital organ functions

2020 DynaMed Plus

2. Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings

Infection prevention and control for novel coronavirus (COVID-19): interim guidance for acute healthcare settings Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings - Canada.ca Language selection Search Search Canada.ca Search Menu Main Menu You are here: Infection prevention and control for coronavirus disease (COVID-19): Interim guidance for acute healthcare settings Table of Contents Introduction The Public Health Agency (...) of Canada (the Agency) develops infection prevention and control (IPC) guidelines to provide evidence-based recommendations to complement provincial/territorial public health efforts in monitoring, preventing, and controlling healthcare-associated infections. This is the preliminary edition of IPC guidance on the coronavirus disease (COVID-19) that was first identified in Wuhan, China. The intended use of this document, infection prevention and control for coronavirus disease (COVID-19): interim

2020 CPG Infobase

3. Novel coronavirus (COVID-19) guidance for acute care

Novel coronavirus (COVID-19) guidance for acute care 1 | Pa g e Ministry of Health Novel Coronavirus (COVID-19) Guidance for Acute Care Version 2 – February 1 1, 2020 This guidance document provides basic information only. It is not intended to take the place of medical advice, communicable diseases surveillance protocols, diagnosis or treatment. What you need to know Acute care settings should: 1. Undertake active screening (asking questions) and passive screening (signage) of patients (...) to more severe diseases such as Middle East Respiratory Syndrome (MERS-CoV), Severe Acute Respiratory Syndrome (SARS-CoV), and COVID-19. A novel coronavirus is a new strain that has not been previously identified in humans. Coronaviruses are zoonotic, meaning they are transmitted between animals and people. Detailed investigations found that SARS-CoV was transmitted from civet cats to humans and MERS-CoV from dromedary camels to humans, likely through bat reservoirs. Several known coronaviruses

2020 CPG Infobase

4. Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community

Interim guidance: public health management of cases and contacts associated with novel coronavirus (COVID-19) in the community Interim Guidance: Public Health Management of cases and contacts associated with novel coronavirus (COVID-19) in the community March 10, 2020 CONTEXT The British Columbia Centre for Disease Control (BCCDC) has adapted the interim guidance from the Public Health Agency of Canada (PHAC) for Regional Health Authorities (RHA) for public health management of human illness (...) caused by the novel coronavirus (COVID-19). The strategy outlined in this guidance is aligned with a containment goal (i.e. to reduce opportunities for transmission to contacts in the community) and is based on the assumption that the virus is primarily spread while the case is symptomatic. This guidance is based on current available scientific evidence and expert opinion and is subject to change as new information on the clinical spectrum, transmissibility and epidemiology becomes available

2020 CPG Infobase

5. Novel Coronavirus (COVID-19) Management In Malaysia

Novel Coronavirus (COVID-19) Management In Malaysia Portal Rasmi Kementerian Kesihatan Malaysia Selamat Datang Ke Portal Rasmi Kementerian Kesihatan Malaysia Broadcast Pengenalan Kami Berita Soalan Lazim Pekeliling Hubungi Kami | | | Bahasa Melayu | | | | COVID-19 (Garis Panduan) Maklumat Terkini Garis Panduan Pusat Media Infografik Video Tanya Doktor GARIS PANDUAN 1. Guidelines 2019 Novel Coronavirus (COVID-19) Management In Malaysia No. 4/2020 Nama Dokumen Download Table of Content Annex 1 (...) Sampel Di Luar Waktu Pejabat, Hujung Minggu Dan Cuti Umum Annex 5a : Guidelines on Laboratory Testing For Novel Coronavirus For Patients Under Inevestigation Annex 5b : Laboratory Testing For Inpatient Annex 5c: Triple Layer Packaging Annex 6a: Health Alert Card Annex 6b: Mental Health Alert Card Annex 7: Notification Form Annex 8 : The Infection Prevention And Control (IPC) Measures Annex 9 : Management Of COVID-19 At Point Of Entry Appendix 1 : Passenger Locator Form (as per WHO/ICAO) Appendix 2

2019 Ministry of Health, Malaysia

6. Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care

Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Health Protection Scotland This document is uncontrolled when printed. Before use check the HPS COVID-19 page to verify this is the current version Novel coronavirus (COVID-19) Guidance for Primary Care Management of patients presenting to primary care Version 10.4 Publication date 27 March 2020 Health Protection Scotland 1 Version History Version Date Summary of changes V1.0 23/01/20 First (...) equipment 12 11.5. Carpeted flooring and soft furnishings 12 11.6. On leaving the room 13 11.7. Cleaning of communal areas 13 11.8. Attending deaths 13 12. Further information 13 Appendix 1: Contact details for local Health Protection Teams 14 Health Protection Scotland 4 Appendix 2: Putting on and removing Personal Protective Equipment (PPE) 15 Instructional video 16 Health Protection Scotland 5 1. Introduction Novel coronavirus (COVID-19) is a new is a new strain of coronavirus first identified

2020 Covid-19 Ad hoc guidelines

7. Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)

Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Abbreviations: ABG, arterial blood gases; CDC, Centers for Disease Control and Prevention; HIV, human immunodeficiency virus. Healthcare providers should immediately notify their local or state health department in the event of a PUI for COVID-19 and should contact and consult with their local and/or state health department for recommendations on testing PUIs for COVID-19. Outpatient (...) Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19) Unlike influenza and other respiratory illnesses, based on a limited number of confirmed COVID-19 cases, pregnant women do not appear to be at increased risk for severe disease. However, given the lack of data and experience with other coronaviruses such as SARS-CoV and MERS-CoV, diligence in evaluating and treating pregnant women is warranted. This algorithm is designed to aid practitioners in promptly

2020 American College of Obstetricians and Gynecologists

8. Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis

Clinical effect of integrated traditional Chinese medicine and western medicine of 2019 novel coronavirus pneumonia (COVID-19): a network meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content

2020 PROSPERO

9. Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials

Chloroquine phosphate for novel coronavirus (COVID-19) pneumonia : a systematic review and meta-analysis of randomised controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

10. A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option

A systematic review of convalescent plasma treatment for SAR coronavirus and MERS coronavirus: a possible reference for a 2019 novel coronavirus (COVID-19) treatment option Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability

2020 PROSPERO

11. Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis

Efficacy of integrative Traditional Chinese and Western medicine for the treatment of patients infected with 2019 novel coronavirus (COVID-19): a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

12. The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis

The risk factors of acquiring severe 2019 novel coronavirus (COVID-19): a meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

13. The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia

The risk factors for death from 2019 novel coronavirus (COVID-19)-infected pneumonia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2020 PROSPERO

14. Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19)

Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) | Australian Government Department of Health Sub menu Search Menu Search Close You are here Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) guides the Australian health sector response. Listen Print Share (...) Loading... Downloads Australian Health Sector Emergency Response Plan for Novel Coronavirus (COVID-19) We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, . Publication date: 18 February 2020 Publication type: Strategy or framework Intended audience: General public Description: The Australian Health Sector Emergency Response Plan for Novel Coronavirus (the COVID-19 Plan) includes: an overview of the national approach

2020 Queensland Health

15. Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence and characteristics of fever in novel coronavirus (COVID-19)-infected adult and paediatric patients:a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility

2020 PROSPERO

16. Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak

Prevalence of symptoms and comorbid conditions in novel coronavirus (COVID-19)-infected adult and paediatric patients: a systematic review and meta-analysis of first three-month data of the outbreak Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2020 PROSPERO

17. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 1 MED CHECK April 2020/ Vol.6 No.16 · Page C N o 16 M ED HECK 2 0 2 0 Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death Editorial The Plague (La Peste in French) Urgent Recommendations Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death 1. Don't use ibuprofen or other NSAIDs 2. Don't use corticosteroids especially in the early phase (...) of Albert Camus (November 7, 1913-January 4, 1960), a novel written in 1947, shortly after the end of World War II. It predicts the status of the current world being swept by the pandemic of the novel coronavirus infection (COVID-19). I read it for the first time when I was in the second grade of junior high school. It's been a long time, but a strange feeling after reading was completely different from other masterpieces I read in those days and has remained in my memory. The second time I read

2020 Med Check - The Informed Prescriber

18. Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2

Five Don'ts to Prevent Novel Coronavirus Infection (COVID-19) and Death - part 2 MED CHECK April 2020/ Vol.6 No.17 · Page 17 C N o 17 M ED HECK 2 0 2 0 Editorial Sin of Being Deceived Urgent Recommendations Five Don'ts to Prevent COVID-19 and Death (Part 2) Five Do's to Prevent COVID-19 and Death Editorial Sin of Being Deceived Urgent Recommendations Five Don’ts to prevent COVID-19 and death (Part 2) 3. Don't use Tamiflu and Xofluza 4. Avoid ACE2 enhancers and (hidden) immunosuppressants 5 (...) season, flu was not very prevalent due to the unusually warm winter. However, a case has been confirmed in which a medical doctor who conducted a rapid testing for a patient suspected influenza was infected with a novel coronavirus (SARS-CoV-2 or COVID-19 virus), because the patient was found infected with SARS-CV-2 later. Therefore, the Japan Medical Association recommended member doctors against testing even in case with suspected flu and recommended diagnosis based on the clinical symptoms [8

2020 Med Check - The Informed Prescriber

19. Novel Coronavirus 2019 (COVID-19)

Novel Coronavirus 2019 (COVID-19) Novel Coronavirus 2019 (COVID-19) | ACOG Clinical Guidance Journals & Publications Patient Education Topics Featured Clinical Topics Hi, Featured Clinical Topics Clinical Guidance Novel Coronavirus 2019 (COVID-19) Practice Advisory March 2020 Jump to Resources Share By reading this page you agree to ACOG's Terms and Conditions. . The Centers for Disease Control and Prevention (CDC) has released and guidance for . Travel Due to the current risk of COVID-19, CDC (...) women. For more information on seasonal influenza and recommendations for pregnant women see the and . The American College of Obstetricians and Gynecologists will continue to closely monitor the evolution of the 2019 novel coronavirus (COVID-19) in collaboration with the CDC. New and updated information will be shared as it becomes available. This Practice Advisory was developed by the American College of Obstetricians and Gynecologists’ Immunization, Infectious Disease, and Public Health

2020 American College of Obstetricians and Gynecologists

20. Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials

Favipiravir for treating novel coronavirus (COVID-19) patients: protocol for a systematic review and meta-analysis of controlled trials Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration

2020 PROSPERO

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>